9,703
Total Claims
$1.7M
Drug Cost
1,470
Beneficiaries
$1,186
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-22%
Cost per patient vs peers
$1,186 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 7,665 claims · $161K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,003 | $867K |
| Sacubitril/Valsartan | 274 | $281K |
| Rivaroxaban | 245 | $236K |
| Dronedarone Hcl | 37 | $48K |
| Empagliflozin | 47 | $40K |
| Alirocumab | 25 | $18K |
| Semaglutide | 12 | $17K |
| Evolocumab | 13 | $16K |
| Flecainide Acetate | 340 | $15K |
| Evolocumab | 13 | $14K |
| Ranolazine | 100 | $9,728 |
| Diltiazem Hcl | 290 | $9,492 |
| Bumetanide | 232 | $8,807 |
| Diltiazem Hcl | 34 | $8,582 |
| Evolocumab | 13 | $8,299 |
Prescribing Profile
Patient Profile
74
Avg Age
57%
Female
1.51
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data